Walther Birgit, Tedin Karsten, Lübke-Becker Antina
Centre for Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Robert-von-Ostertag-Str. 7-13, 14163 Berlin, Germany.
Centre for Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Robert-von-Ostertag-Str. 7-13, 14163 Berlin, Germany.
Vet Microbiol. 2017 Feb;200:71-78. doi: 10.1016/j.vetmic.2016.05.017. Epub 2016 May 27.
Although the problems associated with healthcare-associated infections (HAI) and the emergence of zoonotic and multidrug-resistant pathogens in companion animal (dogs, cats and horses) medicine have been well-known for decades, current progress with respect to practical implementation of infection control programs in veterinary clinics has been limited. Clinical outbreak events reported for methicillin-resistant Staphylooccus aureus (MRSA) and Staphylococcus pseudintermedius (MRSP), extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and multidrug-resistant (MDR) Salmonella Serovars indicate the necessity of infection control strategies for protecting animal patients at risk as well as veterinary personnel. The close bond between humans and their companion animals provides opportunities for exchange of microorganisms, including MDR pathogens. This particular aspect of the "One Health" idea requires more representative surveillance efforts and infection control strategies with respect to animal-species specific characters.
尽管与医疗保健相关感染(HAI)以及伴侣动物(狗、猫和马)医学中出现人畜共患病原体和多重耐药病原体相关的问题几十年来一直广为人知,但目前兽医诊所感染控制计划的实际实施进展有限。针对耐甲氧西林金黄色葡萄球菌(MRSA)和中间型葡萄球菌(MRSP)、产超广谱β-内酰胺酶(ESBL)的大肠杆菌以及多重耐药(MDR)沙门氏菌血清型报告的临床暴发事件表明,需要采取感染控制策略来保护有风险的动物患者以及兽医人员。人类与其伴侣动物之间的紧密联系为包括多重耐药病原体在内的微生物交换提供了机会。“同一健康”理念的这一特殊方面需要针对动物物种的特定特征开展更具代表性的监测工作和感染控制策略。